Wěi Li
Shougang (China)(CN)Rice University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Synthesis and biological activity, Cancer Treatment and Pharmacology, Click Chemistry and Applications
Most-Cited Works
- → Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation(2017)3,123 cited
- → Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer(2022)2,394 cited
- → Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial(2014)1,963 cited
- → HIF-1α pathway: role, regulation and intervention for cancer therapy(2015)1,855 cited
- → An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site(2012)743 cited
- → Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition(2011)623 cited